DNA purification test kit 55 series
Free Circulatingclinicalserum

DNA purification test kit - 55 series - Norgen Biotek - Free Circulating / clinical / serum
DNA purification test kit - 55 series - Norgen Biotek - Free Circulating / clinical / serum
DNA purification test kit - 55 series - Norgen Biotek - Free Circulating / clinical / serum - image - 2
DNA purification test kit - 55 series - Norgen Biotek - Free Circulating / clinical / serum - image - 3
Add to favorites
Compare this product
 

Characteristics

Applications
for DNA purification
Tested parameter
Free Circulating
Sample type
clinical, serum, plasma, maternal blood, cell
Result display time

Min.: 15 min

Max.: 20 min

Sample volume

Min.: 0.01 ml
(0.00034 US fl oz)

Max.: 10 ml
(0.33814 US fl oz)

Description

For rapid and simple purification of cell-free circulating DNA from plasma/serum samples Isolate all sizes of circulating DNA from plasma and serum samples Isolate viral and bacterial DNA Versatile plasma and serum input volumes Concentrate circulating DNA into a flexible elution volume Isolate inhibitor-free cell-free circulating DNA Compatible with Streck Cell-Free DNA BCT® Tubes Purification is based on spin column chromatography that uses Norgen’s proprietary resin separation matrix Professional Tech Support with Senior R&D Scientist Fast and Flexible Ordering Options (online, email, or phone) Volume Discounts Available on Large Quantity Orders* Plasma/Serum Cell-Free Circulating DNA Purification Kits These kits provide a fast, reliable and convenient spin column method for the isolation of high quality, high purity and inhibitor-free cell-free circulating DNA (cfc-DNA) from plasma/serum sample volumes. The purified plasma/serum cfc-DNA is fully compatible with all downstream applications including PCR, qPCR, methylation-sensitive PCR and Southern Blot analysis, microarrays and NGS. Background Plasma/Serum cell-free circulating DNA (cfc-DNA) has the potential to provide biomarkers for certain cancers and disease states as well as fetal DNA in maternal blood. Currently, significant advancements are being made in utilizing cfc-DNA as biomarkers for the early diagnosis, prognosis and monitoring of therapy for several cancer types and autoimmune diseases. Cell-free mitochondrial DNA (cfmtDNA) is also under investigation for its clinical significance. This cfc-DNA is usually present as short fragments of less than 1000 bp.
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.